O

Oric Pharmaceuticals
D

ORIC

9.28000
USD
0.05
(0.49%)
مغلق
حجم التداول
19,435
الربح لكل سهم
-2
العائد الربحي
-
P/E
-5
حجم السوق
790,826,687
أصول ذات صلة
A
ADPT
-0.090
(-0.86%)
10.380 USD
AFRM
AFRM
0.420
(0.68%)
62.080 USD
A
ATNF
0.00000
(0.00%)
0.90000 USD
B
BNGO
-0.06400
(-1.95%)
3.22600 USD
F
FATE
-0.02000
(-1.67%)
1.18000 USD
G
GKOS
-2.210
(-2.16%)
100.090 USD
K
KRYS
0.360
(0.27%)
132.510 USD
M
MGNI
-0.105
(-0.56%)
18.725 USD
V
VCYT
-0.450
(-1.68%)
26.370 USD
المزيد
الأخبار المقالات

العنوان: Oric Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.